MRNA Moderna, Inc.

NASDAQ

$258.38

Moderna, Inc. (MRNA) Earnings News

Earnings press releases, previews and reviews for Moderna, Inc. (MRNA), newest first. Our most recent is preview: Moderna's Tripled Stock Meets a COVID Season Test as Cost Cuts and Flu Launch Plans Face Scrutiny.

Thursday October 29, 2026 2:20 PM ET

Moderna's Tripled Stock Meets a COVID Season Test as Cost Cuts and Flu Launch Plans Face Scrutiny

Earnings Whispers · Preview

Tuesday October 13, 2026 7:00 AM ET

Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026